Neil Gibson

Neil Gibson is currently a Senior Director at AstraZeneca, specializing in oncology and leadership roles. They previously served as a Director in Translational Medicine and Clinical Pharmacology Lead at Boehringer Ingelheim, where they guided early asset teams in the oncology portfolio, notably achieving key milestones for Zongertinib. With a background that includes positions as Team Leader in Translational Oncology Genomics and Lab Head at Zeneca Diagnostics, Neil has extensive experience in the field. They earned a PhD in Organic Chemistry from the University of Aberdeen, where they also completed their undergraduate studies.